These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1117518)

  • 21. Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup.
    Herr HW; Wartinger DD; Fair WR; Oettgen HF
    J Urol; 1992 Apr; 147(4):1020-3. PubMed ID: 1552578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm.
    Donat SM; North A; Dalbagni G; Herr HW
    J Urol; 2004 Feb; 171(2 Pt 1):636-9. PubMed ID: 14713776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival.
    Shipley WU; Rose MA; Perrone TL; Mannix CM; Heney NM; Prout GR
    J Urol; 1985 Oct; 134(4):679-83. PubMed ID: 4032570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.
    Herr HW; Pinsky CM; Whitmore WF; Sogani PC; Oettgen HF; Melamed MR
    J Urol; 1986 Feb; 135(2):265-7. PubMed ID: 3511284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer.
    Solsona E; Iborra I; Dumont R; Rubio-Briones J; Casanova J; Almenar S
    J Urol; 2000 Sep; 164(3 Pt 1):685-9. PubMed ID: 10953125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results in partial bladder resection].
    Lipsky H; Hubmer G
    Chirurg; 1972 Jan; 43(1):43-6. PubMed ID: 5059409
    [No Abstract]   [Full Text] [Related]  

  • 29. Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?
    Jakse G; Loidl W; Seeber G; Hofstädter F
    J Urol; 1987 Jan; 137(1):39-43. PubMed ID: 3795364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology.
    Badalament RA; Gay H; Cibas ES; Herr HW; Whitmore WF; Fair WR; Melamed MR
    J Urol; 1987 Oct; 138(4):763-5. PubMed ID: 3656528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction.
    Freeman JA; Esrig D; Stein JP; Simoneau AR; Skinner EC; Chen SC; Groshen S; Lieskovsky G; Boyd SD; Skinner DG
    Cancer; 1995 Sep; 76(5):833-9. PubMed ID: 8625187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late results in patients treated with pi-mesons for bladder cancer.
    Studer UE; Gerber E; Zimmermann A; Kraft R; von Essen CF
    Cancer; 1993 Jan; 71(2):439-47. PubMed ID: 8422636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracavitary radiation for multiple non-infiltrating bladder tumours.
    Wallace DM
    Br J Urol; 1971 Apr; 43(2):177-80. PubMed ID: 5579476
    [No Abstract]   [Full Text] [Related]  

  • 34. The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia.
    Mameghan H; Fisher RJ; Watt WH; Meagher MJ; Rosen IM; Mameghan J; Brook S; Tynan AP; Korbel EI; Millard RJ
    Cancer; 1992 Jun; 69(11):2771-8. PubMed ID: 1571908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder cancer: results of radical cystectomy for invasive and recurrent superficial tumors.
    Drago JR; Rohner TJ
    J Urol; 1983 Sep; 130(3):460-2. PubMed ID: 6887357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of cobalt 60 teletherapy in bladder carcinoma].
    Vielberg H; Schnepper E
    Strahlentherapie; 1967 Sep; 134(1):1-12. PubMed ID: 5588804
    [No Abstract]   [Full Text] [Related]  

  • 37. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
    Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of malignant tumors of the bladder].
    Pauk J; Tomás J
    Rozhl Chir; 1971 Sep; 50(9):489-93. PubMed ID: 4106168
    [No Abstract]   [Full Text] [Related]  

  • 39. [Consideration of therapeutic choice for grade 3 superficial bladder cancer].
    Noguchi S; Kubota Y; Takase K; Masuda M; Yao M; Hosaka M; Miura T; Kondoh I; Kawasaki C; Moriyama M
    Hinyokika Kiyo; 1996 Sep; 42(9):635-8. PubMed ID: 8918660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bladder carcinoma treated by irradiation only].
    Pum H; Reichelt H; Schimatzek A
    Helv Chir Acta; 1973 Sep; 40(4):473-6. PubMed ID: 4753384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.